Pack of 2 ML
Old MRP ₹93.03
MRP ₹87.22
₹69.78
₹43.61/ML
Use current location
Login to view saved addresses
100% genuine medicines
Safe & secure payments
15 days Easy returns
Prescription required for this medicine
Store Below 30o C
CompositionCadigran 1 MG Injection 2 ML is used in managing nausea and vomiting caused by cancer treatments and surgery. It belongs to the class of antiemetic medicines.
In addition to its primary use, it helps prevent nausea and vomiting triggered by radiation therapy and is effective for postoperative nausea. Consult your doctor for dosage and inform them of existing conditions or medications. Report any side effects promptly and complete the treatment duration as advised.
Cadigran 1 MG Injection 2 ML is used to manage nausea and vomiting caused by chemotherapy, radiation therapy, and postoperative recovery.
When administering Cadigran 1 MG Injection 2 ML, follow these steps:
The injection is to be administered only by a trained healthcare professional.
It should not be self-administered at home.
Always follow your doctor's advice regarding the timing of your injections.
If you are due an injection but cannot reach your doctor's office, consult your doctor about rescheduling.
Do not attempt to catch up on missed doses without consulting your doctor.
Cadigran 1 MG Injection 2 ML is administered intravenously.
Cadigran 1 MG Injection 2 ML may cause side effects such as headache, constipation, diarrhoea, abdominal pain, dizziness, insomnia, and fatigue. These are generally mild. If these side effects persist or worsen, consult your doctor.
Most side effects are temporary and generally harmless, which resolve on discontinuing Cadigran 1 MG Injection 2 ML. However, if you experience serious side effects or worsening symptoms, please consult your doctor.
Here are some suggestions to manage common side effects:
Dyspepsia: Follow the diet plan recommended by your doctor.
Fatigue: Avoid activities your doctor has advised against and follow their recommendations.
Cadigran 1 MG Injection 2 ML contains granisetron (1 mg), which acts on your body in the following ways:
5-HT3 Receptor Antagonist: Granisetron works by specifically targeting and blocking the 5-HT3 receptors located in your body's chemoreceptor trigger zone and gastrointestinal tract. These receptors are part of the mechanism that triggers the urge to vomit.
Serotonin Inhibitor: When granisetron blocks the 5-HT3 receptors, it effectively inhibits the activity of serotonin. Serotonin is a neurotransmitter that plays a significant role in initiating the vomiting reflex. This action helps reduce nausea and vomiting associated with cancer treatments and surgery.
Caution is advised while taking Cadigran 1 MG Injection 2 ML if you are pregnant. It is best to consult your doctor before taking this medicine.
Always consult your doctor before using this medicine if you are breastfeeding.
To ensure safety, it's recommended to discuss your alcohol consumption with your doctor.
Even though Cadigran 1 MG Injection 2 ML doesn't require dosage adjustment in patients with liver issues, it's advisable to consult your doctor before using this medicine if you have liver-related concerns.
Cadigran 1 MG Injection 2 ML doesn't necessitate dosage adjustment in patients with kidney impairment. However, if you have a history of kidney problems, it's wise to discuss this with your doctor before taking this medicine.
Cadigran 1 MG Injection 2 ML may cause dizziness or somnolence. If affected, refrain from driving or operating heavy machinery. Always discuss these risks with your doctor.
If you're allergic to granisetron or any other ingredients in Cadigran 1 MG Injection 2 ML, do not use this medicine. Contact your doctor immediately if you experience any allergic reactions.
The use of Cadigran 1 MG Injection 2 ML has been established as safe and effective in children aged above 2 years for the prevention of nausea and vomiting induced by chemotherapy. Always consult your doctor before giving any medicine to a child.
No overall differences were observed between elderly and younger patients regarding the safety or effectiveness of Cadigran 1 MG Injection 2 ML. Nonetheless, some older individuals may be more sensitive. Caution is advised if patients are above 70 years of age.
Cadigran 1 MG Injection 2 ML interacts with the following medicines:
Serotonergic medications: Using Cadigran 1 MG Injection 2 ML with other serotonergic medicines like SSRI antidepressants (such as fluoxetine and sertraline) or triptans (like sumatriptan and zolmitriptan) can increase the risk of serotonin syndrome, a potentially serious condition.
Antifungals: If you take strong CYP3A4 inhibitors like ketoconazole or itraconazole alongside Cadigran 1 MG Injection 2 ML, the latter may increase the levels of granisetron in your blood, which could lead to more side effects.
Antibiotics: Taking strong CYP3A4 inducers such as rifampin alongside Cadigran 1 MG Injection 2 ML may reduce granisetron levels in your blood. This could make the medicine less effective in managing your symptoms.
No specific food interactions have been reported with Cadigran 1 MG Injection 2 ML.
Cadigran 1 MG Injection 2 ML interacts with the following diseases:
Gastrointestinal motility disorders: Cadigran 1 MG Injection 2 ML might slow down your gut movements. So, if you have conditions that affect bowel transit and motility, you should be cautious.
Cardiovascular disease: Cadigran 1 MG Injection 2 ML can cause QT prolongation, a heart rhythm disorder. So, if you have pre-existing heart rhythm problems or cardiac conduction disorders, be careful while using Cadigran 1 MG Injection 2 ML.
Your doctor should administer the daily dose of Cadigran 1 MG Injection 2 ML as prescribed. The dosage may vary based on individual factors, such as the severity of the condition and response to treatment. It is important to follow the prescribed dosage and not exceed it without consulting your doctor.
An overdose is highly unlikely for this medication as it is administered by a skilled healthcare professional.
If you forget to take your Cadigran 1 MG Injection 2 ML as scheduled, consult your doctor for advice.
Store Cadigran 1 MG Injection 2 ML in the refrigerator or (2°C - 8°C). Do Not Freeze.
Protect the injection from light.
It's crucial to keep this medicine out of the reach of children.
Pay attention to the expiry date and make sure you use this medicine before it.
When undergoing chemotherapy or radiotherapy, eating small, frequent meals can help manage nausea and vomiting. This applies to both adults and if Cadigran 1 MG Injection 2 ML is prescribed for your child.
Staying hydrated is crucial, particularly if vomiting occurs. Sip water or clear liquids slowly throughout the day to maintain hydration levels.
| Available Dosage Types | Injection |
| Habit Forming | No |
| Ailment | Chemotherapy-induced nausea, Radiation-induced vomiting, Postoperative nausea |
| Drug Category | 5-HT3 Antagonist |
| Therapeutic Category | Antiemetic |
Cadigran 1 MG Injection 2 ML is used to prevent and manage nausea and vomiting caused by cancer chemotherapy, radiation therapy, and surgery.
Cadigran 1 MG Injection 2 ML contains granisetron which blocks the action of a substance in the body called serotonin, reducing the urge to vomit or feel nauseous.
It should only be used if clearly needed and after consulting your doctor.
Consult your doctor before using it while breastfeeding.
Yes, children above 2 years can use Cadigran 1 MG Injection 2 ML to manage nausea and vomiting caused by chemotherapy. Always consult a doctor first.
Yes, some common side effects include headache, constipation, diarrhoea, abdominal pain, dizziness, insomnia and fatigue.
Some medicines may interact with Cadigran 1 MG Injection 2 ML. Always tell your doctor about any other medications you're taking to ensure safe use.
Check out Editorial Policy
Heron Therapeutics, Inc. (2016). Highlights of prescribing information for SUSTOL [Prescribing information]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022445s000lbl.pdf
Unknown. (n.d.). Granisetron hydrochloride injection. In Unknown [Unknown]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/077963Orig1s016,%20077297Orig1s016,%20078392Orig1s017lbl.pdf
Granisetron hydrochloride. (2018, August 7). Cancer.gov. https://www.cancer.gov/about-cancer/treatment/drugs/granisetronhydrochloride
Granisetron: Uses, interactions, mechanism of action | DrugBank Online. (n.d.). DrugBank. https://go.drugbank.com/drugs/DB00889
We, at Truemeds make a diligent attempt to deliver accurate, expert- drafted and thoroughly reviewed medicine related information to our consumers. However, it should, by no means, be considered a substitute for prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact we detest any form of self medication without expert advice. The sole purpose of the information on our portal is to educate our consumers, which helps improve the communication between a doctor and a patient. The information by no means is complete in its entirety and should not be used to diagnose or treat any medical condition. No amount of information can replace the experience and expertise of a doctor, therefore his/her advice always holds priority and should be followed appropriately.
50.1% CHEAPER
100 + users bought this instead
...View more
...View more
Company
About UsHealth ArticleHealth StoriesHealth LibraryDiseases & Health ConditionsAyurvedaUnderstanding Generic MedicinesAll MedicinesAll BrandsNeed HelpFAQSecuritySavings CalculatorSubscribe
Registered Office Address
Grievance Officer
Download Truemeds
Contact Us
Our customer representative team is available 7 days a week from 9 am - 9 pm.
v4.12.1
2026 - Truemeds | All rights reserved. Our content is for informational purposes only. See additional information.
Our Payment Partners
